High-mobility Group Box 1 Promotes Epithelial-to-mesenchymal Transition in Crystalline Silica Induced Pulmonary Inflammation and Fibrosis.

Jixuan Ma,Yiju Xu,Wei Li,Yun Zhou,Dongming Wang,Meng Yang,Bin Wang,Weihong Chen
DOI: https://doi.org/10.1016/j.toxlet.2020.05.016
IF: 4.271
2020-01-01
Toxicology Letters
Abstract:Silicosis is an inflammatory and fibrotic lung disease caused by prolonged inhalation of silica. The potential role of high-mobility group box-1 (HMGB-1) and its underlying mechanisms in silicosis remain unclear. In this study, intratracheal instillation of a silica suspension was used to establish silicosis in male C57BL/6 mice. To elucidate the effects of HMGB-1 on the pathogenesis of silicosis, we used HMGB-1 neutralizing antibody (anti-HMGB-1) and recombinant HMGB-1 (rmHMGB-1) to abrogate or increase the HMGB-1 levels, respectively. At days 7, 28, and 84, the accumulation of macrophages and neutrophils decreased by anti-HMGB-1 treatment. The expression levels of interleukin-6 and tumor necrosis factor-a in lung increased in response to silica exposure across three time points; anti-HMGB-1 could alleviate those expressions at day 28 and 84. In contrast, rmHMGB-1 aggravated this process. At days 28 and 84, the protein expression of fibronectin and col1a1 decreased in the silica+ anti-HMGB-1 groups but increased in silica+ rmHMGB-1 groups compared to mice with silica alone. Further study suggested that HMGB-1-mediated epithelial-mesenchymal transition participated in the development of silicosis. In conclusion, the findings demonstrate that HMGB-1 participates in the pathogenesis of silicosis and may represent a potential therapeutic target for the treatment of silicosis.
What problem does this paper attempt to address?